Omid Moradi

A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID‐19

Amir Behnam Kharazmi, Omid Moradi, Mehrdad Haghighi et al. · Immunity Inflammation and Disease · 2021 · 45 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Decreased in‐hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID‐19

Mohammad Haji Aghajani, Omid Moradi, Hossein Amini et al. · Journal of Medical Virology · 2021 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID‐19; a retrospective cohort study

Mohammad Haji Aghajani, Omid Moradi, Hamed Azhdari Tehrani et al. · International Journal of Clinical Practice · 2021 · 21 citations · Full text

Medicine, Pharmacotherapy, Cardiovascular Pharmacotherapy +16

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting.

Omid Moradi, Iman Karimzadeh, Dorna Davani-Davari et al. · PubMed · 2020 · 16 citations · Full text

Medicine, Nephrology, Pharmacokinetics +15

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei et al. · International Immunopharmacology · 2021 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10